nodes	percent_of_prediction	percent_of_DWPC	metapath
Gliclazide—Glyburide—gestational diabetes	0.342	1	CrCtD
Gliclazide—type 2 diabetes mellitus—gestational diabetes	0.231	1	CtDrD
Gliclazide—ABCC8—Glyburide—gestational diabetes	0.0717	0.439	CbGbCtD
Gliclazide—KCNJ11—Glyburide—gestational diabetes	0.0619	0.38	CbGbCtD
Gliclazide—Glimepiride—Glyburide—gestational diabetes	0.0488	0.224	CrCrCtD
Gliclazide—Tolazamide—Glyburide—gestational diabetes	0.0488	0.224	CrCrCtD
Gliclazide—Glipizide—Glyburide—gestational diabetes	0.0438	0.201	CrCrCtD
Gliclazide—Glisoxepide—Glyburide—gestational diabetes	0.0399	0.183	CrCrCtD
Gliclazide—Chlorpropamide—Glyburide—gestational diabetes	0.0367	0.168	CrCrCtD
Gliclazide—ALB—Glyburide—gestational diabetes	0.0135	0.0827	CbGbCtD
Gliclazide—CYP2C19—Glyburide—gestational diabetes	0.00874	0.0536	CbGbCtD
Gliclazide—CYP2C9—Glyburide—gestational diabetes	0.00727	0.0446	CbGbCtD
Gliclazide—Epigastric fullness—Glyburide—gestational diabetes	0.00528	0.122	CcSEcCtD
Gliclazide—Hypopituitarism—Glyburide—gestational diabetes	0.00382	0.0885	CcSEcCtD
Gliclazide—Erythropenia—Glyburide—gestational diabetes	0.00382	0.0885	CcSEcCtD
Gliclazide—Porphyria hepatic—Glyburide—gestational diabetes	0.00303	0.0703	CcSEcCtD
Gliclazide—Disulfiram like reaction—Glyburide—gestational diabetes	0.00303	0.0703	CcSEcCtD
Gliclazide—Alcoholism—Glyburide—gestational diabetes	0.00254	0.0588	CcSEcCtD
Gliclazide—Porphyria cutanea tarda—Glyburide—gestational diabetes	0.00219	0.0508	CcSEcCtD
Gliclazide—Porphyria non-acute—Glyburide—gestational diabetes	0.00206	0.0477	CcSEcCtD
Gliclazide—Alcohol abuse—Glyburide—gestational diabetes	0.00174	0.0404	CcSEcCtD
Gliclazide—Central nervous system disorder—Glyburide—gestational diabetes	0.00159	0.0368	CcSEcCtD
Gliclazide—Allergic cutaneous angiitis—Glyburide—gestational diabetes	0.001	0.0232	CcSEcCtD
Gliclazide—Alcohol intolerance—Glyburide—gestational diabetes	0.001	0.0232	CcSEcCtD
Gliclazide—Reaction gastrointestinal—Glyburide—gestational diabetes	0.000953	0.0221	CcSEcCtD
Gliclazide—Cerebrovascular disorder—Glyburide—gestational diabetes	0.000712	0.0165	CcSEcCtD
Gliclazide—Nephropathy—Glyburide—gestational diabetes	0.000668	0.0155	CcSEcCtD
Gliclazide—Leukocytoclastic vasculitis—Glyburide—gestational diabetes	0.000649	0.015	CcSEcCtD
Gliclazide—Digestion impaired—Glyburide—gestational diabetes	0.000476	0.011	CcSEcCtD
Gliclazide—Heartburn—Glyburide—gestational diabetes	0.000462	0.0107	CcSEcCtD
Gliclazide—Cholestasis—Glyburide—gestational diabetes	0.000419	0.00971	CcSEcCtD
Gliclazide—Jaundice cholestatic—Glyburide—gestational diabetes	0.000362	0.0084	CcSEcCtD
Gliclazide—Hepatic function abnormal—Glyburide—gestational diabetes	0.000264	0.00613	CcSEcCtD
Gliclazide—Deafness—Glyburide—gestational diabetes	0.000258	0.00599	CcSEcCtD
Gliclazide—Hepatic failure—Glyburide—gestational diabetes	0.000257	0.00596	CcSEcCtD
Gliclazide—Haemolytic anaemia—Glyburide—gestational diabetes	0.000256	0.00593	CcSEcCtD
Gliclazide—Renal failure acute—Glyburide—gestational diabetes	0.00025	0.0058	CcSEcCtD
Gliclazide—Visual disturbance—Glyburide—gestational diabetes	0.000244	0.00565	CcSEcCtD
Gliclazide—Renal impairment—Glyburide—gestational diabetes	0.000243	0.00563	CcSEcCtD
Gliclazide—Arthritis—Glyburide—gestational diabetes	0.000238	0.00551	CcSEcCtD
Gliclazide—Hypoglycaemia—Glyburide—gestational diabetes	0.000237	0.00549	CcSEcCtD
Gliclazide—Hyponatraemia—Glyburide—gestational diabetes	0.000232	0.00538	CcSEcCtD
Gliclazide—Diplopia—Glyburide—gestational diabetes	0.000231	0.00536	CcSEcCtD
Gliclazide—VEGFA—islet of Langerhans—gestational diabetes	0.000213	0.197	CbGeAlD
Gliclazide—Abdominal distension—Glyburide—gestational diabetes	0.000201	0.00466	CcSEcCtD
Gliclazide—Pancytopenia—Glyburide—gestational diabetes	0.00019	0.0044	CcSEcCtD
Gliclazide—Photosensitivity reaction—Glyburide—gestational diabetes	0.000182	0.00422	CcSEcCtD
Gliclazide—Jaundice—Glyburide—gestational diabetes	0.000173	0.00402	CcSEcCtD
Gliclazide—Agranulocytosis—Glyburide—gestational diabetes	0.000166	0.00385	CcSEcCtD
Gliclazide—Hepatitis—Glyburide—gestational diabetes	0.00016	0.0037	CcSEcCtD
Gliclazide—Visual impairment—Glyburide—gestational diabetes	0.000154	0.00357	CcSEcCtD
Gliclazide—KCNJ11—islet of Langerhans—gestational diabetes	0.000152	0.141	CbGeAlD
Gliclazide—Eye disorder—Glyburide—gestational diabetes	0.000149	0.00346	CcSEcCtD
Gliclazide—ABCC8—islet of Langerhans—gestational diabetes	0.00014	0.13	CbGeAlD
Gliclazide—Malnutrition—Glyburide—gestational diabetes	0.000139	0.00323	CcSEcCtD
Gliclazide—Erythema—Glyburide—gestational diabetes	0.000139	0.00323	CcSEcCtD
Gliclazide—VEGFA—uterus—gestational diabetes	0.000139	0.129	CbGeAlD
Gliclazide—KCNJ11—Type II diabetes mellitus—ADIPOQ—gestational diabetes	0.000137	0.103	CbGpPWpGaD
Gliclazide—VEGFA—adipose tissue—gestational diabetes	0.000136	0.126	CbGeAlD
Gliclazide—Tremor—Glyburide—gestational diabetes	0.00013	0.00302	CcSEcCtD
Gliclazide—Anaemia—Glyburide—gestational diabetes	0.000129	0.00298	CcSEcCtD
Gliclazide—Angioedema—Glyburide—gestational diabetes	0.000127	0.00295	CcSEcCtD
Gliclazide—Leukopenia—Glyburide—gestational diabetes	0.000124	0.00289	CcSEcCtD
Gliclazide—Convulsion—Glyburide—gestational diabetes	0.000121	0.00279	CcSEcCtD
Gliclazide—Arthralgia—Glyburide—gestational diabetes	0.000118	0.00275	CcSEcCtD
Gliclazide—Myalgia—Glyburide—gestational diabetes	0.000118	0.00275	CcSEcCtD
Gliclazide—Confusional state—Glyburide—gestational diabetes	0.000114	0.00265	CcSEcCtD
Gliclazide—VEGFA—vagina—gestational diabetes	0.000113	0.105	CbGeAlD
Gliclazide—Nervous system disorder—Glyburide—gestational diabetes	0.000111	0.00258	CcSEcCtD
Gliclazide—Thrombocytopenia—Glyburide—gestational diabetes	0.000111	0.00258	CcSEcCtD
Gliclazide—Hyperhidrosis—Glyburide—gestational diabetes	0.00011	0.00254	CcSEcCtD
Gliclazide—Hypotension—Glyburide—gestational diabetes	0.000106	0.00246	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Glyburide—gestational diabetes	0.000103	0.0024	CcSEcCtD
Gliclazide—Paraesthesia—Glyburide—gestational diabetes	0.000102	0.00236	CcSEcCtD
Gliclazide—Dyspnoea—Glyburide—gestational diabetes	0.000101	0.00235	CcSEcCtD
Gliclazide—Dyspepsia—Glyburide—gestational diabetes	9.99e-05	0.00232	CcSEcCtD
Gliclazide—ABCC8—FOXA2 and FOXA3 transcription factor networks—GCK—gestational diabetes	9.83e-05	0.0743	CbGpPWpGaD
Gliclazide—Gastrointestinal disorder—Glyburide—gestational diabetes	9.8e-05	0.00227	CcSEcCtD
Gliclazide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—GCK—gestational diabetes	9.54e-05	0.072	CbGpPWpGaD
Gliclazide—Feeling abnormal—Glyburide—gestational diabetes	9.35e-05	0.00217	CcSEcCtD
Gliclazide—Gastrointestinal pain—Glyburide—gestational diabetes	9.28e-05	0.00215	CcSEcCtD
Gliclazide—Urticaria—Glyburide—gestational diabetes	9.02e-05	0.00209	CcSEcCtD
Gliclazide—Abdominal pain—Glyburide—gestational diabetes	8.97e-05	0.00208	CcSEcCtD
Gliclazide—Hypersensitivity—Glyburide—gestational diabetes	8.36e-05	0.00194	CcSEcCtD
Gliclazide—Asthenia—Glyburide—gestational diabetes	8.14e-05	0.00189	CcSEcCtD
Gliclazide—Pruritus—Glyburide—gestational diabetes	8.03e-05	0.00186	CcSEcCtD
Gliclazide—Diarrhoea—Glyburide—gestational diabetes	7.77e-05	0.0018	CcSEcCtD
Gliclazide—KCNJ11—head—gestational diabetes	7.46e-05	0.0691	CbGeAlD
Gliclazide—Vomiting—Glyburide—gestational diabetes	7.22e-05	0.00167	CcSEcCtD
Gliclazide—Rash—Glyburide—gestational diabetes	7.16e-05	0.00166	CcSEcCtD
Gliclazide—Dermatitis—Glyburide—gestational diabetes	7.15e-05	0.00166	CcSEcCtD
Gliclazide—Headache—Glyburide—gestational diabetes	7.11e-05	0.00165	CcSEcCtD
Gliclazide—ABCC8—head—gestational diabetes	6.87e-05	0.0637	CbGeAlD
Gliclazide—Nausea—Glyburide—gestational diabetes	6.74e-05	0.00156	CcSEcCtD
Gliclazide—VEGFA—HIF-1-alpha transcription factor network—GCK—gestational diabetes	6.5e-05	0.0491	CbGpPWpGaD
Gliclazide—VEGFA—Angiogenesis—FGF2—gestational diabetes	5.67e-05	0.0428	CbGpPWpGaD
Gliclazide—VEGFA—Glypican 1 network—FGF2—gestational diabetes	5.32e-05	0.0402	CbGpPWpGaD
Gliclazide—CYP2C19—vagina—gestational diabetes	4.29e-05	0.0397	CbGeAlD
Gliclazide—ABCC8—Neuronal System—GLS2—gestational diabetes	4.12e-05	0.0311	CbGpPWpGaD
Gliclazide—KCNJ11—Neuronal System—GLS2—gestational diabetes	4e-05	0.0302	CbGpPWpGaD
Gliclazide—KCNJ11—Type II diabetes mellitus—TNF—gestational diabetes	3.93e-05	0.0297	CbGpPWpGaD
Gliclazide—VEGFA—HIF-1-alpha transcription factor network—LEP—gestational diabetes	3.32e-05	0.0251	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—GCK—gestational diabetes	3.26e-05	0.0247	CbGpPWpGaD
Gliclazide—VEGFA—Differentiation Pathway—FGF2—gestational diabetes	3.26e-05	0.0246	CbGpPWpGaD
Gliclazide—ALB—FOXA2 and FOXA3 transcription factor networks—GCK—gestational diabetes	3.17e-05	0.024	CbGpPWpGaD
Gliclazide—VEGFA—Integrins in angiogenesis—FGF2—gestational diabetes	2.62e-05	0.0198	CbGpPWpGaD
Gliclazide—VEGFA—Endochondral Ossification—FGF2—gestational diabetes	2.59e-05	0.0195	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—CYP19A1—gestational diabetes	2.45e-05	0.0185	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—AR—gestational diabetes	2.38e-05	0.018	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—AR—gestational diabetes	2.32e-05	0.0175	CbGpPWpGaD
Gliclazide—VEGFA—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	2.05e-05	0.0155	CbGpPWpGaD
Gliclazide—CYP2C19—Biological oxidations—GGCT—gestational diabetes	2.01e-05	0.0152	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	1.97e-05	0.0149	CbGpPWpGaD
Gliclazide—CYP2C9—Biological oxidations—GGCT—gestational diabetes	1.83e-05	0.0138	CbGpPWpGaD
Gliclazide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	1.62e-05	0.0123	CbGpPWpGaD
Gliclazide—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	1.6e-05	0.0121	CbGpPWpGaD
Gliclazide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	1.48e-05	0.0112	CbGpPWpGaD
Gliclazide—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	1.46e-05	0.011	CbGpPWpGaD
Gliclazide—VEGFA—Allograft Rejection—TNF—gestational diabetes	1.33e-05	0.0101	CbGpPWpGaD
Gliclazide—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	1.32e-05	0.00994	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—GCK—gestational diabetes	1.3e-05	0.00981	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—GCK—gestational diabetes	1.21e-05	0.00911	CbGpPWpGaD
Gliclazide—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	1.2e-05	0.00907	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—GGCT—gestational diabetes	1.19e-05	0.00897	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—GGCT—gestational diabetes	1.15e-05	0.0087	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	1.08e-05	0.00815	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—ADIPOQ—gestational diabetes	1.07e-05	0.00807	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—GLS2—gestational diabetes	1.04e-05	0.00784	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—GLS2—gestational diabetes	1.01e-05	0.0076	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—TNF—gestational diabetes	7.72e-06	0.00583	CbGpPWpGaD
Gliclazide—ALB—SLC-mediated transmembrane transport—GCK—gestational diabetes	7.66e-06	0.00578	CbGpPWpGaD
Gliclazide—CYP2C19—Biological oxidations—CYP19A1—gestational diabetes	6.99e-06	0.00528	CbGpPWpGaD
Gliclazide—CYP2C19—Metapathway biotransformation—CYP19A1—gestational diabetes	6.9e-06	0.00521	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—TNF—gestational diabetes	6.67e-06	0.00504	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—LEP—gestational diabetes	6.64e-06	0.00502	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	6.57e-06	0.00496	CbGpPWpGaD
Gliclazide—CYP2C9—Biological oxidations—CYP19A1—gestational diabetes	6.38e-06	0.00482	CbGpPWpGaD
Gliclazide—CYP2C9—Metapathway biotransformation—CYP19A1—gestational diabetes	6.29e-06	0.00475	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—LEPR—gestational diabetes	6.29e-06	0.00475	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—NAMPT—gestational diabetes	5.69e-06	0.0043	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—GCK—gestational diabetes	5.65e-06	0.00427	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—NAMPT—gestational diabetes	5.51e-06	0.00417	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—GCK—gestational diabetes	5.48e-06	0.00414	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—TNF—gestational diabetes	5.42e-06	0.0041	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—FGF2—gestational diabetes	5.04e-06	0.00381	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—MTNR1B—gestational diabetes	4.97e-06	0.00375	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—RBP4—gestational diabetes	4.84e-06	0.00366	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—TNF—gestational diabetes	4.31e-06	0.00326	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—CYP19A1—gestational diabetes	4.13e-06	0.00312	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—CYP19A1—gestational diabetes	4.01e-06	0.00303	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—GCK—gestational diabetes	3.89e-06	0.00294	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GGCT—gestational diabetes	3.83e-06	0.00289	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GGCT—gestational diabetes	3.44e-06	0.0026	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GLS2—gestational diabetes	3.35e-06	0.00253	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GGCT—gestational diabetes	3.13e-06	0.00237	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—TNF—gestational diabetes	3.07e-06	0.00232	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GLS2—gestational diabetes	3e-06	0.00227	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	2.99e-06	0.00226	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GLS2—gestational diabetes	2.74e-06	0.00207	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	2.69e-06	0.00203	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	2.45e-06	0.00185	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—LEP—gestational diabetes	2.21e-06	0.00167	CbGpPWpGaD
Gliclazide—ALB—Metabolism—NAMPT—gestational diabetes	1.83e-06	0.00139	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GCK—gestational diabetes	1.82e-06	0.00138	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—FGF2—gestational diabetes	1.68e-06	0.00127	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—NAMPT—gestational diabetes	1.65e-06	0.00124	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GCK—gestational diabetes	1.64e-06	0.00124	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—NAMPT—gestational diabetes	1.5e-06	0.00113	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GCK—gestational diabetes	1.49e-06	0.00113	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CYP19A1—gestational diabetes	1.33e-06	0.00101	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CYP19A1—gestational diabetes	1.2e-06	0.000903	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CYP19A1—gestational diabetes	1.09e-06	0.000824	CbGpPWpGaD
